Patents by Inventor Pascal Suplie

Pascal Suplie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MORPHINE SULFATE MICROGRANULES, MANUFACTURING PROCESS AND PHARMACEUTICAL PREPARATIONS
    Publication number: 20020028246
    Abstract: The present invention relates to a novel oral immediate-release morphine sulfate formulation in the form of microgranules.
    Type: Application
    Filed: February 16, 1999
    Publication date: March 7, 2002
    Inventors: PATRICE DEBREGEAS, GERARD LEDUC, PASCAL OURY, PASCAL SUPLIE
  • Sustained-release microgranules containing Diltiazem as the active principle
    Patent number: 6228395
    Abstract: Novel forms of sustained-release microgranules (LP) containing diltiazem are disclosed. The microgranules consist of a neutral granular carrier coated with an active layer including diltiazem or a pharmaceutically acceptable salt thereof as the active principle, a surfactant and a binder, and an outer layer providing sustained release of the active principle (layer LP).
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: May 8, 2001
    Assignee: Laboratories des Produits Ethiques Ethypharm
    Inventors: Patrice DeBregeas, Gérard LeDuc, Pascal Oury, Pascal Suplie
  • Spheroids containing tiagabine, preparation process and pharmaceutical compositions
    Patent number: 6139877
    Abstract: The present invention relates to a novel pharmaceutical form, in the form of spheroids, containing tiagabine as active principle. The invention also covers the process for the preparation of such spheroids and multiparticulate pharmaceutical preparations, such as tablets, containing these spheroids. These pharmaceutical preparations are intended for the delivery of the spheroids they contain, and are characterized by the absence of an adverse effect on the release profile of the tiagabine contained in the spheroids following a possible compression step.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: October 31, 2000
    Assignee: Laboratoires des Produits Ethiques Ethypharm
    Inventors: Patrice Debregeas, Gerard Leduc, Pascal Oury, Pascal Suplie
  • Spheroids, preparation process and pharmaceutical compositions
    Patent number: 6077544
    Abstract: The present invention relates to a novel pharmaceutical form, in the form of spheroids, containing one or more active principles, which the exception of tiagabine.The invention also covers the process for the preparation of such spheroids and multiparticulate pharmaceutical preparations, such as tablets, containing these spheroids.These pharmaceutical preparations are intended for the delivery of the spheroids they contain, and are characterized by the absence of an adverse effect on the release profile of the active principle(s) following a possible compression step.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: June 20, 2000
    Assignee: Laboratoires des Products Ethiques Ethypharm
    Inventors: Patrice Debregeas, Gerard Leduc, Pascal Oury, Pascal Suplie